JM Smucker Moves on Profit Beat; Vail Resorts Down on Full Year Guidance Cut | Stock Movers

Why It Matters

The GSK deal underscores big pharma’s push into oncology to replace fading HIV revenues and could reshape its U.S. pipeline; Smucker’s results highlight pricing power but also consumer strain and margin pressures; Vail’s guidance cut signals how climate and weather variability can materially hit leisure revenues and investor sentiment.

Summary

GSK agreed to buy a U.S. biotech for about $10.6 billion in cash, paying roughly $124 a share — a roughly 40% premium — to secure two late-stage lung-cancer candidates that could become blockbusters and help offset upcoming HIV drug patent expiries. J.M. Smucker beat fourth-quarter profit and sales expectations as pricing increases, not volume growth, drove revenue; volume fell for some coffee brands while Cafe Bustelo gained, and management is pursuing cost cuts and Hostess stabilization. Vail Resorts cut full-year guidance after a weak winter and declining season-pass sales, particularly across western resorts, reflecting weather-driven demand shortfalls. Stocks reacted: GSK softened early, Smucker rose about 4.7%, and Vail weakened on the outlook revision.

Original Description

On this episode of Stock Movers with Alexis Christoforous:

- Nuvalent (NUVL) shares are higher on news GSK agreed to buy Nuvalent for $10.6 billion, securing a US biotech firm developing treatments for lung cancer.

- JM Smucker (SJM) shares are on the move after it posted fourth-quarter profits that beat Wall Street expectations as higher prices helped boost the packaged food company.

- Vail Resorts (MTN) is dropping after the ski resort operator cut its net income guidance for the full year, attributing the reduction to “historically challenging” weather conditions in the western US. The guidance missed the average analyst estimate.

--------

Watch Bloomberg Radio LIVE on YouTube

Weekdays 7am-6pm ET

Saturday & Sunday 7am-10am ET

WATCH HERE: http://bit.ly/3vTiACF

Follow us on X: https://twitter.com/BloombergRadio

Subscribe to our Podcasts:

Bloomberg Daybreak: http://bit.ly/3DWYoAN

Bloomberg Surveillance: http://bit.ly/3OPtReI

Bloomberg Intelligence: http://bit.ly/3YrBfOi

Balance of Power: http://bit.ly/3OO8eLC

Bloomberg Businessweek: http://bit.ly/3IPl60i

Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:

Apple CarPlay: https://apple.co/486mghI

Android Auto: https://bit.ly/49benZy

Visit our YouTube channels:

Bloomberg Podcasts: https://www.youtube.com/bloombergpodcasts

Bloomberg Television: https://www.youtube.com/@markets

Bloomberg Originals: https://www.youtube.com/bloomberg

Quicktake: https://www.youtube.com/@BloombergQuicktake